Exacerbation Reduction in Patients with Asthma Following Escalation to FF/UMEC/VI from ICS/LABA: Retrospective Cohort Study.
Saved in:
| Title: | Exacerbation Reduction in Patients with Asthma Following Escalation to FF/UMEC/VI from ICS/LABA: Retrospective Cohort Study. |
|---|---|
| Authors: | Baptist AP; Division of Allergy and Clinical Immunology, Henry Ford Health and MI State University Health Sciences, Detroit, MI, USA., Paczkowski R; Global Real-World Evidence and Health Outcomes Research Organization, GSK, Collegeville, PA, USA., Germain G; Group d'Analyse, SRI Ltée, Montréal, QC, Canada., Klimek J; Analysis Group, Inc, Boston, MA, USA., Laliberté F; Group d'Analyse, SRI Ltée, Montréal, QC, Canada., Schell RC; Analysis Group, Inc, Menlo Park, CA, USA., Forero-Schwanhaeuser S; US Medical Affairs, GSK, Durham, NC, USA., Moore A; Global Medical Affairs, General Medicines, GSK, London, UK., Noorduyn SG; Global Real-World Evidence and Health Outcomes Research Organization, GSK, 100 Milverton Drive, Suite 800, Mississauga, ON, L5R 4H1, Canada. stephen.g.noorduyn@gsk.com.; Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, ON, Canada. stephen.g.noorduyn@gsk.com. |
| Source: | Pulmonary therapy [Pulm Ther] 2025 Dec; Vol. 11 (4), pp. 725-740. Date of Electronic Publication: 2025 Oct 28. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Country of Publication: United States NLM ID: 101687144 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2364-1746 (Electronic) Linking ISSN: 23641754 NLM ISO Abbreviation: Pulm Ther Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41148557 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Exacerbation Reduction in Patients with Asthma Following Escalation to FF/UMEC/VI from ICS/LABA: Retrospective Cohort Study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Baptist+AP%22">Baptist AP</searchLink>; Division of Allergy and Clinical Immunology, Henry Ford Health and MI State University Health Sciences, Detroit, MI, USA.<br /><searchLink fieldCode="AU" term="%22Paczkowski+R%22">Paczkowski R</searchLink>; Global Real-World Evidence and Health Outcomes Research Organization, GSK, Collegeville, PA, USA.<br /><searchLink fieldCode="AU" term="%22Germain+G%22">Germain G</searchLink>; Group d'Analyse, SRI Ltée, Montréal, QC, Canada.<br /><searchLink fieldCode="AU" term="%22Klimek+J%22">Klimek J</searchLink>; Analysis Group, Inc, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Laliberté+F%22">Laliberté F</searchLink>; Group d'Analyse, SRI Ltée, Montréal, QC, Canada.<br /><searchLink fieldCode="AU" term="%22Schell+RC%22">Schell RC</searchLink>; Analysis Group, Inc, Menlo Park, CA, USA.<br /><searchLink fieldCode="AU" term="%22Forero-Schwanhaeuser+S%22">Forero-Schwanhaeuser S</searchLink>; US Medical Affairs, GSK, Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Moore+A%22">Moore A</searchLink>; Global Medical Affairs, General Medicines, GSK, London, UK.<br /><searchLink fieldCode="AU" term="%22Noorduyn+SG%22">Noorduyn SG</searchLink>; Global Real-World Evidence and Health Outcomes Research Organization, GSK, 100 Milverton Drive, Suite 800, Mississauga, ON, L5R 4H1, Canada. stephen.g.noorduyn@gsk.com.; Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, ON, Canada. stephen.g.noorduyn@gsk.com. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101687144%22">Pulmonary therapy</searchLink> [Pulm Ther] 2025 Dec; Vol. 11 (4), pp. 725-740. <i>Date of Electronic Publication: </i>2025 Oct 28. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer%22">Springer </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101687144 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2364-1746 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223641754%22">23641754 </searchLink><i>NLM ISO Abbreviation: </i>Pulm Ther <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41148557 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s41030-025-00327-w Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 725 Titles: – TitleFull: Exacerbation Reduction in Patients with Asthma Following Escalation to FF/UMEC/VI from ICS/LABA: Retrospective Cohort Study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Baptist AP – PersonEntity: Name: NameFull: Paczkowski R – PersonEntity: Name: NameFull: Germain G – PersonEntity: Name: NameFull: Klimek J – PersonEntity: Name: NameFull: Laliberté F – PersonEntity: Name: NameFull: Schell RC – PersonEntity: Name: NameFull: Forero-Schwanhaeuser S – PersonEntity: Name: NameFull: Moore A – PersonEntity: Name: NameFull: Noorduyn SG IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 12 Text: 2025 Dec Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 2364-1746 Numbering: – Type: volume Value: 11 – Type: issue Value: 4 Titles: – TitleFull: Pulmonary therapy Type: main |
| ResultId | 1 |